Loading clinical trials...
Loading clinical trials...
The investigators in this study are concerned about the harmful effects of oxygen exposure in newborn infants, particularly at high concentrations. Inhaled nitric oxide (iNO) is an FDA approved drug f...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Florida
Collaborators
NCT04898114 · Persistent Pulmonary Hypertension of Newborn
NCT00371241 · Persistent Fetal Circulation Syndrome, Diaphragmatic Hernia, and more
NCT01203423 · Infant, Newborn, Infant, Low Birth Weight, and more
NCT00005776 · Infant, Newborn, Hypertension, Pulmonary, and more
NCT00005323 · Lung Diseases, Cardiovascular Diseases, and more
Shands Hospital at the University of Florida
Gainesville, Florida
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions